Showing 1421-1430 of 1717 results for "".
- Visual Impairment in Hispanic/Latinx People May Be Associated With Worse Measures of Cognitionhttps://practicalneurology.com/news/visual-impairment-in-hispaniclatinx-people-may-be-associated-with-worse-measures-of-cognition/2469980/In a study conducted at the University of Miami Miller School of Medicine, Hispanic/Latinx people with self-reported vision problems had worse verbal fluency, memory, and processing speed/executive function). This correlation was found both at baseline and after 7 years of follow-up, with visual
- Tic Development Not Associated With Strep in Children of Parents With Chronic Tic Disordershttps://practicalneurology.com/news/tics-development/2469813/A study published in Neurology found there was no link between a strep throat infection and the development of tics in children who have a parent or sibling with a chronic tic disorder. In the study, 24% of the children (n=61) developed tics. At 2-year follow up assessments, 7 more chil
- Loss of Consciousness With Concussion May Be Associated With Later Increased Disabilityhttps://practicalneurology.com/news/loss-of-consciousness-with-concussion-may-be-associated-with-later-increased-disability/2469600/According to a study published in Neurology, individuals who experienced a concussion where they lost consciousness may be more likely to have some disability or limitations later in life. The participants in the study were asked whether a physical, mental or emotional problem keeps or l
- Study Suggests SSRIs Not Associated with Increased Risk of Intracerebral Hemorrhagehttps://practicalneurology.com/news/study-suggests-ssris-not-associated-with-increased-risk-of-intracerebral-hemorrhage/2469514/Review of medical records for 127,915 people who had a stroke between 2010 and 2019 showed that 17,009 (13.3%) had been prescribed a selective serotonin reuptake inhibitor (SSRI) before they had the stroke. Of the 127,915 cases of stroke, 11% of those who had been prescribed an SSRI had an intrac
- Nabiximols for Multiple Sclerosis-Associated Spasticity Phase 3 Studies in US Beginhttps://practicalneurology.com/news/nabiximols-for-multiple-sclerosis-associated-spasticity-phase-3-studies-in-us-begin/2469416/The first phase 3 clinical trial (NCT04203498) studying the cannabis-derived medicine nabiximols (Sativex; GW Pharmaceuticals, Carlsbad, CA) for spasticity in multiple sclerosis (MS) has been initi
- Possible Association Between Risk of Alzheimer Disease and Disturbed Sleep Patternshttps://practicalneurology.com/news/possible-association-between-risk-of-alzheimer-disease-and-disturbed-sleep-patterns/2469356/A retrospective medical record review, study published in the August 19, 2020 online issue of Neurology, suggests that, although disturbed sleep patterns do not cause Alzheimer disease (AD), individuals with high genetic risk for developing AD may be more likely to have those patterns.
- Ocrelizumab Treatment Associated with Significant Decreases in Blood Levels of Neurofilament Lighthttps://practicalneurology.com/news/ocrelizumab-treatment-associated-with-significant-decreases-in-blood-levels-of-neurofilament-light/2469017/Biomarker data from the ORATORIO and OPERA I clinical trials (NCT01194570 and NCT01247324) of ocrelizumab (Ocrevus; Genentech, South San Francisco, CA) for relapsing and pri
- Combination Drug Shows Promise for Treating Alzheimer's-Associated Agitationhttps://practicalneurology.com/news/combination-drug-shows-promise-for-treating-alzheimers-associated-agitation/2468788/A combination of deudextromethorphan hydrobromide and quinidine sulfate (AVP-786; Avanir Pharmaceuticals, Alisa Viejo, CA) is being studied as potential treatment of moderate-to-severe agitation in patients with Alzheimer's dementia (AD) (
- The AAIC Presents Lifetime Achievement Awards in Alzheimer Disease Researchhttps://practicalneurology.com/news/the-aaic-presents-lifetime-achievement-awards-in-alzheimers-disease-research/2470542/Three awardees were recognized at the 2024 meeting of the Alzheimer’s Association International Conference (AAIC), receiving AAIC Lifetime Achievement Awards in Alzheimer disease (AD) research. These awards celebrate the leadership, research, and mentorship contributions of senior
- Phenogroups of Migraine Identified With Artificial Intelligence-Guided Topologic Mappinghttps://practicalneurology.com/news/phenogroups-of-migraine-identified-with-artificial-intelligence-guided-topologic-mapping/2469941/Migraine is increasingly as a as a heterogeneous disorder, with a wide variety of headache characteristics, associated symptoms, and treatment responses. In a study presented at the American Headache Society meeting in Denver, CO June 9-12, 2022, Chia-Chun Chiang, MD, senior assoc